Raymond James Financial Services Advisors Inc. Grows Stake in ICU Medical, Inc. (NASDAQ:ICUI)

Raymond James Financial Services Advisors Inc. grew its position in ICU Medical, Inc. (NASDAQ:ICUIGet Rating) by 85.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,841 shares of the medical instruments supplier’s stock after purchasing an additional 2,690 shares during the quarter. Raymond James Financial Services Advisors Inc.’s holdings in ICU Medical were worth $880,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Comerica Bank grew its holdings in shares of ICU Medical by 21.8% during the second quarter. Comerica Bank now owns 11,343 shares of the medical instruments supplier’s stock valued at $1,917,000 after buying an additional 2,030 shares during the last quarter. Victory Capital Management Inc. grew its holdings in shares of ICU Medical by 3.6% during the second quarter. Victory Capital Management Inc. now owns 17,279 shares of the medical instruments supplier’s stock valued at $2,841,000 after buying an additional 597 shares during the last quarter. WCM Investment Management LLC grew its holdings in shares of ICU Medical by 50.6% during the third quarter. WCM Investment Management LLC now owns 176,728 shares of the medical instruments supplier’s stock valued at $26,771,000 after buying an additional 59,403 shares during the last quarter. Oak Thistle LLC purchased a new stake in shares of ICU Medical during the second quarter valued at $256,000. Finally, Chartwell Investment Partners LLC grew its holdings in shares of ICU Medical by 2.6% during the second quarter. Chartwell Investment Partners LLC now owns 8,431 shares of the medical instruments supplier’s stock valued at $1,386,000 after buying an additional 210 shares during the last quarter. 93.88% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other ICU Medical news, VP Virginia Ruth Sanzone sold 325 shares of the company’s stock in a transaction dated Tuesday, November 15th. The shares were sold at an average price of $160.12, for a total value of $52,039.00. Following the completion of the transaction, the vice president now owns 3,046 shares in the company, valued at $487,725.52. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 7.30% of the company’s stock.

ICU Medical Trading Up 5.8 %

Shares of ICU Medical stock opened at $187.05 on Monday. The firm has a 50-day simple moving average of $160.81 and a two-hundred day simple moving average of $160.23. The company has a market cap of $4.49 billion, a P/E ratio of -119.90 and a beta of 0.53. ICU Medical, Inc. has a fifty-two week low of $128.90 and a fifty-two week high of $251.73. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.17 and a current ratio of 2.45.

ICU Medical (NASDAQ:ICUIGet Rating) last issued its quarterly earnings data on Monday, November 7th. The medical instruments supplier reported $1.53 earnings per share for the quarter, topping analysts’ consensus estimates of $1.15 by $0.38. The business had revenue of $597.86 million during the quarter, compared to the consensus estimate of $562.90 million. ICU Medical had a negative net margin of 1.90% and a positive return on equity of 6.51%. As a group, equities analysts predict that ICU Medical, Inc. will post 5.18 earnings per share for the current fiscal year.

Analysts Set New Price Targets

ICUI has been the subject of a number of research reports. StockNews.com upgraded shares of ICU Medical from a “sell” rating to a “hold” rating in a research report on Thursday, November 17th. Raymond James downgraded shares of ICU Medical from an “outperform” rating to a “market perform” rating in a research report on Tuesday, November 8th. Finally, KeyCorp decreased their target price on shares of ICU Medical from $225.00 to $200.00 in a research report on Tuesday, November 8th.

About ICU Medical

(Get Rating)

ICU Medical, Inc engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors.

See Also

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUIGet Rating).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.